July 1, 2025 Where to Rent Stable Turkish Datacenter Proxies?
June 24, 2025 PayPal’s News Analysis—A Short and Medium-Term Price Forecast
June 10, 2025 Understanding Accounting and Bookkeeping Services for Business Success
May 27, 2025 How much does a Turkish passport cost?
May 22, 2025 How Measurement and Mix Modeling Drive Better Business Decisions
G1 Therapeutics (GTHX) stock forecast for 2026
Updated: May 31, 2025 (04:02)
Sector: HealthcareThe share price of G1 Therapeutics, Inc. (GTHX) now
50/200 Day Moving Average: $ / $
This figure corresponds to the Average Price over the previous 50/200 days. For G1 Therapeutics stocks, the 50-day moving average is the support level today.
For G1 Therapeutics stocks, the 200-day moving average is the support level today.
Are you interested in G1 Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the G1 Therapeutics stock price in 2026. How much will one G1 Therapeutics share be worth in 2026? Is it worth taking profit / loss on GTHX stock now or waiting? What are analysts' forecasts for G1 Therapeutics stock?
We forecast G1 Therapeutics stock performance using neural networks based on historical data on GTHX stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
G1 Therapeutics, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for G1 Therapeutics analysts is $. Today 200 Day Moving Average is the support level ( $). 50 Day Moving Average is the support level ( $).
Historical and forecast chart of G1 Therapeutics, Inc. stock
The chart below shows the historical price of G1 Therapeutics stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the GTHX stock price can be found in the table below.
G1 Therapeutics, Inc. is a clinical biopharmaceutical company that develops and delivers innovative treatments that improve the lives of people with cancer.
G1 Therapeutics (GTHX) Forecast for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 5.89 | 5.43 | 7.06 | 23.18 % |
| Mar | 5.70 | 4.77 | 6.63 | 28.05 % |
| Mar | 6.94 | 6.38 | 8.27 | 22.88 % |
| May | 7.56 | 6.89 | 8.99 | 23.39 % |
| May | 8.01 | 6.58 | 9.52 | 30.88 % |
| Jul | 8.23 | 6.54 | 9.82 | 33.46 % |
| Jul | 8.87 | 7.43 | 9.54 | 22.09 % |
| Aug | 10.45 | 9.27 | 11.13 | 16.74 % |
| Oct | 9.91 | 7.88 | 10.69 | 26.29 % |
| Oct | 9.94 | 7.87 | 10.48 | 24.85 % |
| Dec | 12.33 | 11.30 | 14.53 | 22.23 % |
| Dec | 12.03 | 9.66 | 13.85 | 30.26 % |
G1 Therapeutics information and performance
N/A
Market capitalization of the G1 Therapeutics, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of GTHX shares in the company outstanding by the market price of one share.
EBITDA of G1 Therapeutics is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
G1 Therapeutics price target for 2026 by month
Target values for the price of one G1 Therapeutics share for Jan 2026.
In Jan, the Positive dynamics for G1 Therapeutics, Inc. shares will prevail with possible monthly volatility of 23.179% volatility is expected.
Pessimistic target level: 5.43
Optimistic target level: 7.06
Target values for the price of one G1 Therapeutics share for Mar 2026.
In Mar, the Negative dynamics for G1 Therapeutics, Inc. shares will prevail with possible monthly volatility of 28.050% volatility is expected.
Pessimistic target level: 4.77
Optimistic target level: 6.63
Target values for the price of one G1 Therapeutics share for Mar 2026.
In Mar, the Positive dynamics for G1 Therapeutics, Inc. shares will prevail with possible monthly volatility of 22.883% volatility is expected.
Pessimistic target level: 6.38
Optimistic target level: 8.27
Target values for the price of one G1 Therapeutics share for May 2026.
In May, the Positive dynamics for G1 Therapeutics, Inc. shares will prevail with possible monthly volatility of 23.389% volatility is expected.
Pessimistic target level: 6.89
Optimistic target level: 8.99
Target values for the price of one G1 Therapeutics share for May 2026.
In May, the Positive dynamics for G1 Therapeutics, Inc. shares will prevail with possible monthly volatility of 30.883% volatility is expected.
Pessimistic target level: 6.58
Optimistic target level: 9.52
Target values for the price of one G1 Therapeutics share for Jul 2026.
In Jul, the Positive dynamics for G1 Therapeutics, Inc. shares will prevail with possible monthly volatility of 33.456% volatility is expected.
Pessimistic target level: 6.54
Optimistic target level: 9.82
Target values for the price of one G1 Therapeutics share for Jul 2026.
In Jul, the Positive dynamics for G1 Therapeutics, Inc. shares will prevail with possible monthly volatility of 22.090% volatility is expected.
Pessimistic target level: 7.43
Optimistic target level: 9.54
Target values for the price of one G1 Therapeutics share for Aug 2026.
In Aug, the Positive dynamics for G1 Therapeutics, Inc. shares will prevail with possible monthly volatility of 16.736% volatility is expected.
Pessimistic target level: 9.27
Optimistic target level: 11.13
Target values for the price of one G1 Therapeutics share for Oct 2026.
In Oct, the Negative dynamics for G1 Therapeutics, Inc. shares will prevail with possible monthly volatility of 26.291% volatility is expected.
Pessimistic target level: 7.88
Optimistic target level: 10.69
Target values for the price of one G1 Therapeutics share for Oct 2026.
In Oct, the Positive dynamics for G1 Therapeutics, Inc. shares will prevail with possible monthly volatility of 24.848% volatility is expected.
Pessimistic target level: 7.87
Optimistic target level: 10.48
Target values for the price of one G1 Therapeutics share for Dec 2026.
In Dec, the Positive dynamics for G1 Therapeutics, Inc. shares will prevail with possible monthly volatility of 22.229% volatility is expected.
Pessimistic target level: 11.30
Optimistic target level: 14.53
Target values for the price of one G1 Therapeutics share for Dec 2026.
In Dec, the Negative dynamics for G1 Therapeutics, Inc. shares will prevail with possible monthly volatility of 30.255% volatility is expected.
Pessimistic target level: 9.66
Optimistic target level: 13.85
Related stocks from Healthcare sector
